Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» AstraZeneca hands off another Amgen-partnered drug in a $1.5B deal with an acquisitive Allergan
AstraZeneca hands off another Amgen-partnered drug in a $1.5B deal with an acquisitive Allergan
AstraZeneca hands off another Amgen-partnered drug in a $1.5B deal with an acquisitive Allergan
Submitted by
admin
on October 3, 2016 - 10:09am
Source:
Endpoints
News Tags:
AstraZeneca
Amgen
Allergan
MEDI2070
ulcerative colitis
Crohn's Disease
Headline:
AstraZeneca hands off another Amgen-partnered drug in a $1.5B deal with an acquisitive Allergan
Do Not Allow Advertisers to Use My Personal information
